INTEGRA LIFESCIENCES HOLDINGS CORP
IART · XNASCIK 917520fmd_1V6R6T38RNKJ9DSKSFV7D1C8XRManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2026, 71 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 992 | 1,188 | 1,472 | 1,518 | 1,372 | 1,542 | 1,558 | 1,542 | 1,611 | 1,635 |
| Cost of revenue | 349 | 436 | 571 | 565 | 521 | 598 | 587 | 657 | 728 | 804 |
| Gross profit | 643 | 753 | 901 | 953 | 851 | 945 | 970 | 885 | 882 | 832 |
| Research and development | 58 | 63 | 78 | 80 | 77 | 93 | 101 | 104 | 115 | 99 |
| Selling, general and administrative | 456 | 624 | 691 | 688 | 595 | 637 | 616 | 657 | 717 | 700 |
| Operating income | 115 | 45 | 111 | 94 | 151 | 197 | 239 | 112 | 28 | (493) |
| Interest expense | 26 | 35 | 65 | 54 | 72 | 50 | 50 | 51 | 71 | 86 |
| Interest and investment income | 0 | 0 | 3 | 11 | 9 | 7 | 12 | 17 | 20 | 18 |
| Other non-operating income (expense) | 1 | 1 | 8 | 10 | 4 | 19 | 12 | 4 | 4 | (2) |
| Income before taxes | 90 | 11 | 57 | 60 | 94 | 215 | 214 | 81 | (18) | (564) |
| Income tax expense | 16 | (53) | (3) | 10 | (40) | 46 | 33 | 13 | (11) | (47) |
| Net income from continuing operations | 75 | 65 | 61 | 50 | 134 | 169 | 181 | 68 | (7) | (516) |
| Net income | 75 | 65 | 61 | 50 | 134 | 169 | 181 | 68 | (7) | (516) |